Description
Global Markets Direct ' s latest Pharmaceutical and Healthcare disease pipeline guide Bullous Pemphigoid – Pipeline Review , H2 2016 , provides an overview of the Bullous Pemphigoid ( Dermatology ) pipeline landscape .
Bullous pemphigoid is a chronic , inflammatory , subepidermal , blistering disease . If untreated , it can persist for monthsor years , with periods of spontaneous remissions and exacerbations . The disease can be fatal , particularly in patientswho are debilitated .
Request a sample of this report @ http :// orbisresearch . com / contacts / request-sample / 171204 .
Report Highlights Global Markets Direct ' s Pharmaceutical and Healthcare latest pipeline guide Bullous Pemphigoid – Pipeline Review , H2 2016 , provides comprehensive information on the therapeutics under development for Bullous Pemphigoid ( Dermatology ), complete with analysis by stage of development , drug target , mechanism of action ( MoA ), route of administration ( RoA ) and molecule type . The guide covers the descriptive pharmacological action of the therapeutics , its complete research and development history and latest news and press releases .
Purchase a copy of this report @ http :// orbisresearch . com / contact / purchase / 171204 . For more information contact sales @ orbisresearch . com
The Bullous Pemphigoid ( Dermatology ) pipeline guide also reviews of key players involved in therapeutic development for Bullous Pemphigoid and features dormant and discontinued projects . The guide covers therapeutics under Development by Companies / Universities / Institutes , the molecules developed by Companies in Phase II , Phase I , Preclinical and Discovery stages are 1 , 1 , 2 and 1 respectively .
Bullous Pemphigoid ( Dermatology ) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios , enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage . The guide is built using data and information sourced from Global Markets Direct ’ s proprietary databases , company / university websites , clinical trial registries , conferences , SEC filings , investor presentations and featured press releases from company / university sites and industry-specific third party sources . Additionally , various dynamic tracking processes ensure that the most recent developments are captured on a real time basis .
Browse Complete Report @ http :// orbisresearch . com / reports / index / bullous-pemphigoid-pipelinereview-h2-2016 .
Some points from TOC :
Table of Contents 2 List of Tables 4 www . orbisresearch . com ; + 1 ( 214 ) 884-6817 ; + 9120-64101019